http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2010127336-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4873 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48 |
| filingDate | 2008-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2010127336-A |
| titleOfInvention | PHARMACEUTICAL FOR THE TREATMENT OF BENEFIT HYPERPLASIA OF THE PROSTATE |
| abstract | 1. The use of at least one protease for the manufacture of a medicament for the treatment and / or prevention of benign prostate hypertrophy / hyperplasia, wherein the medicament is suitable for parenteral administration, wherein at least one protease is selected from the group consisting of plant proteases and microorganisms, and it is administered in an amount of from 1 to 100 mg / kg body weight. ! 2. The use according to claim 1, in which the plant protease is selected from the group consisting of bromelin, papain, ficin, ananine, balance, caricain, faustasain, hieronymim, karatazin, macrodontain, penguin, cumumisin, actinidia. ! 3. The use according to claim 1, in which the protease of the microorganisms is selected from the group consisting of nattokinase, brinase, cyprosis, spherical, subtilisin and mutanase. !4. The use according to claim 1, wherein the protease from non-mammalian animals is selected from the group consisting of krilenzyme, batroxobin, lumbrokinase, alfimerase and mutanase. ! 5. The use according to claim 1, in which at least one protease is contained in the drug in an amount of from 5 to 100% wt./weight., Preferably from 20 to 80% wt./weight., More preferably from 30 up to 70% w / w. ! 6. The use according to claim 1, wherein at least one protease is administered to an individual in an amount of from 2 to 50 mg / kg, preferably from 5 to 20 mg / kg of body weight. ! 7. The use according to claim 1, wherein the drug further comprises at least one pharmaceutically acceptable carrier, diluent and / or excipient, preferably a binding agent, excipient, disintegrant, lubricant, preservative and / or coating. ! 8. The use according to claim 1, for which |
| priorityDate | 2007-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.